Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

Links shared publicly online about this topic.

  • 1,001
    total visits

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

news-medical.net —

XenoPort, Inc. announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented tomorrow at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan.

View full resource at news-medical.net

Tags: Genetic, Fragile X

  • Share

Most Recently Shared on July 23, 2010 at 6:45 pm By:

Parkinsons_News News-Medical.Net

Parkinson's Disease: Preclinical data of new acamprosate prodrug to be presented at International Fragile X Confer... http://bit.ly/9CjzBm

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

News-Medical.Net News-Medical.Net

Advertisement